Skip to main content
SpringerLink
Log in

Targeting a Genetic Killer

Novel Disease-Modifying Therapies for Cystic Fibrosis

  • Emerging Technology
  • Published:
Pharmaceutical & Diagnostic Innovation

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Reference

  1. Targeted Genetics ends CF gene therapy study [online]. Media release: 17 March 2005. Available from http:www.targen.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Targeting a Genetic Killer. Pharmaceutical & Diagnostic Innovation 4, 10–13 (2006). https://doi.org/10.1007/BF03257062

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03257062

Keywords

Search

Navigation